🇩🇪 Xeljanz in Germany

BfArM authorised Xeljanz on 22 March 2017

Marketing authorisation

BfArM — authorised 22 March 2017

  • Marketing authorisation holder: PFIZER EUROPE MA EEIG
  • Status: approved

Xeljanz in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Xeljanz approved in Germany?

Yes. BfArM authorised it on 22 March 2017.

Who is the marketing authorisation holder for Xeljanz in Germany?

PFIZER EUROPE MA EEIG holds the German marketing authorisation.